These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19019998)

  • 21. Renal transplant and secondary hyperparathyroidism.
    Gøransson LG; Bergrem H
    Scand J Urol Nephrol; 2007; 41(6):553-7. PubMed ID: 18050015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States.
    LaClair RE; Hellman RN; Karp SL; Kraus M; Ofner S; Li Q; Graves KL; Moe SM
    Am J Kidney Dis; 2005 Jun; 45(6):1026-33. PubMed ID: 15957131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease.
    Strugnell SA; Sprague SM; Ashfaq A; Petkovich M; Bishop CW
    Am J Nephrol; 2019; 49(4):284-293. PubMed ID: 30878999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of renal function in primary hyperparathyroidism.
    Walker MD; Nickolas T; Kepley A; Lee JA; Zhang C; McMahon DJ; Silverberg SJ
    J Clin Endocrinol Metab; 2014 May; 99(5):1885-92. PubMed ID: 24527717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis.
    Chonchol M; Locatelli F; Abboud HE; Charytan C; de Francisco AL; Jolly S; Kaplan M; Roger SD; Sarkar S; Albizem MB; Mix TC; Kubo Y; Block GA
    Am J Kidney Dis; 2009 Feb; 53(2):197-207. PubMed ID: 19110359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.
    Coresh J; Astor BC; Greene T; Eknoyan G; Levey AS
    Am J Kidney Dis; 2003 Jan; 41(1):1-12. PubMed ID: 12500213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A threshold value of estimated glomerular filtration rate that predicts changes in serum 25-hydroxyvitamin D levels: 4th Korean National Health and Nutritional Examination Survey 2008.
    Oh YJ; Kim M; Lee H; Lee JP; Kim H; Kim S; Oh KH; Joo KW; Lim CS; Kim S; Kim YS; Kim DK
    Nephrol Dial Transplant; 2012 Jun; 27(6):2396-403. PubMed ID: 22262736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic abnormalities are present in adults with elevated serum cystatin C.
    Muntner P; Vupputuri S; Coresh J; Uribarri J; Fox CS
    Kidney Int; 2009 Jul; 76(1):81-8. PubMed ID: 19295502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low.
    Ennis JL; Worcester EM; Coe FL; Sprague SM
    J Nephrol; 2016 Feb; 29(1):63-70. PubMed ID: 25736620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Markers of mineral metabolism are not associated with aortic pulse wave velocity in community-living elderly persons: the Health Aging and Body Composition study.
    Madero M; Wassel CL; Peralta CA; Najjar SS; Sutton-Tyrrell K; Fried LF; de Boer IH; Shlipak MG; Newman AB; Hausman D; Sarnak MJ; Kritchevsky SB; Ix JH;
    Am J Hypertens; 2011 Jul; 24(7):755-61. PubMed ID: 21436791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation between Calcium, Phosphorus, Calcium-Phosphorus Index and iPTH in Chronic Kidney Disease Patients.
    Adhikary LP; Yadava SK; Pokharel A; Khadka D; Thakur R
    J Nepal Health Res Counc; 2015; 13(29):50-3. PubMed ID: 26411713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary hyperparathyroidism after kidney transplantation: a cross-sectional study.
    Marcén R; Ponte B; Rodríguez-Mendiola N; Fernández Rodriguez A; Galeano C; Villafruela JJ; Teruel JL; Burgos FJ; Ortuño J
    Transplant Proc; 2009; 41(6):2391-3. PubMed ID: 19715929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis.
    Charytan C; Coburn JW; Chonchol M; Herman J; Lien YH; Liu W; Klassen PS; McCary LC; Pichette V
    Am J Kidney Dis; 2005 Jul; 46(1):58-67. PubMed ID: 15983958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posterior urethral valves: Metabolic consequences in a cohort of patients.
    Sarhan O; Nakshabandi Z; Alghanbar M; Alotay A; Sherif I; Whitehead C; El-Husseini A
    J Pediatr Urol; 2015 Aug; 11(4):216.e1-6. PubMed ID: 26096436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. International variation in the management of mineral bone disorder in patients with chronic kidney disease: Results from CKDopps.
    Liabeuf S; McCullough K; Young EW; Pisoni R; Zee J; Reichel H; Pecoits-Filho R; Port FK; Stengel B; Csomor PA; Metzger M; Robinson B; Massy ZA
    Bone; 2019 Dec; 129():115058. PubMed ID: 31493530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for chronic kidney disease complications in US adults: racial implications of a single GFR threshold.
    Ibrahim HN; Wang C; Ishani A; Collins AJ; Foley RN
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1792-9. PubMed ID: 18784208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal status in adult volunteers in central Italy: results from Family Abbott Renal Disease Monitoring Project (FARM) study.
    Gorini A; Costanzo AM; Egan CG; di Luzio Paparatti U
    J Nephrol; 2012; 25(4):523-32. PubMed ID: 21956766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.
    Sánchez Fructuoso AI; Maestro ML; Calvo N; De La Orden V; Pérez Flores I; Vidaurreta M; Valero R; Fernández-Pérez C; Barrientos A
    Transplant Proc; 2012 Nov; 44(9):2551-4. PubMed ID: 23146451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
    Levin A; Djurdjev O; Beaulieu M; Er L
    Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.